What companies are ZYBT's competitors?

Zhengye Biotechnology Holding Limited (ZYBT)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does ZYBT compare to its peers?

The peer comparison table on this page shows Zhengye Biotechnology Holding Limited (ZYBT) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does ZYBT operate in?

Zhengye Biotechnology Holding Limited (ZYBT) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

ZYBT

Zhengye Biotechnology Holding Limited

NASDAQ·Drug Manufacturers, Specialty & Generic · Healthcare

$1.73$0.03−1.70%

After hours·$1.71−1.16%

Market cap$81.99M·Market closed·Aug 28 8:00 PM UTC

Frequently Asked Questions About ZYBT

What companies are ZYBT's competitors?: Zhengye Biotechnology Holding Limited (ZYBT)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does ZYBT compare to its peers?: The peer comparison table on this page shows Zhengye Biotechnology Holding Limited (ZYBT) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does ZYBT operate in?: Zhengye Biotechnology Holding Limited (ZYBT) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

ZYBT

Zhengye Biotechnology Holding Limited

NASDAQ·Drug Manufacturers, Specialty & Generic · Healthcare

$1.73$0.03−1.70%

After hours·$1.71−1.16%

Market cap$81.99M·Market closed·Aug 28 8:00 PM UTC

Peers


CRDL	Cardiol Therapeutics Inc.	$1.94	$223.6M
PDEX	Pro-Dex, Inc.	$62.56	$199.7M
SRZN	Surrozen, Inc.	$22.42	$167.6M
APYX	Apyx Medical Corporation	$3.08	$129.7M
ONCY	Oncolytics Biotech Inc.	$0.83	$83.3M
SERA	Sera Prognostics, Inc.	$2.07	$79.1M
EXOZ	eXoZymes, Inc.	$7.17	$66.5M
TIL	Instil Bio, Inc.	$7.58	$51.4M
IXHL	Incannex Healthcare Limited	$3.64	$43.6M
ATOS	Atossa Therapeutics, Inc.	$2.58	$25.7M

Frequently Asked Questions About ZYBT

What companies are ZYBT's competitors?: Zhengye Biotechnology Holding Limited (ZYBT)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does ZYBT compare to its peers?: The peer comparison table on this page shows Zhengye Biotechnology Holding Limited (ZYBT) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does ZYBT operate in?: Zhengye Biotechnology Holding Limited (ZYBT) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.